PLEASE NOTE: When registering for an account, make sure all of your information including your mailing address is current and matches what we have on file in our pharmacy system. If you receive a “No Match Found” error, please contact us to confirm.
GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds
In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.
Health News is provided as a service to Athens Creekside Drugs site users by HealthDay. Athens Creekside Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.